Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 2550  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page

Table of Contents 
Year : 2011  |  Volume : 56  |  Issue : 6  |  Page : 763-765
Dress syndrome with sepsis, acute respiratory distress syndrome and pneumomediastinum

1 Department of Pediatric Medicine, Institute of Child Health, Kolkata, India
2 Department of Pediatric Dermatology, Institute of Child Health, Kolkata, India

Date of Web Publication14-Jan-2012

Correspondence Address:
Prabhas Prasun Giri
C-1, Anandan, 173, Sarat Ghosh Garden Road, Dhakuria, Kolkata-31
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-5154.91850

Rights and Permissions


Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome reflects a serious hypersensitivity reaction to drugs, and is characterized by skin rash, fever, lymph node enlargement, and internal organ involvement. So far, numerous drugs such as sulfonamides, phenobarbital, sulfasalazine, carbamazepine, and phenytoin have been reported to cause DRESS syndrome. We report a case of a 10-year-old girl who developed clinical manifestations of fever, rash, lymphadenopathy, hypereosinophilia, and visceral involvement (hepatitis and pneumonitis) after taking phenobarbital for seizures, with subsequent development of sepsis, acute respiratory distress syndrome (ARDS) and spontaneous air leak syndrome (pnemothorax and pneumomediastinum). She was put on steroids and various antibiotics and was ventilated, but ultimately succumbed to sepsis and pulmonary complications.

Keywords: Acute respiratory distress syndrome, dress syndrome, drug hypersensitivity, pneumomediastinum, pneumonia, sepsis

How to cite this article:
Giri PP, Roy S, Bhattyacharya S, Pal P, Dhar S. Dress syndrome with sepsis, acute respiratory distress syndrome and pneumomediastinum. Indian J Dermatol 2011;56:763-5

How to cite this URL:
Giri PP, Roy S, Bhattyacharya S, Pal P, Dhar S. Dress syndrome with sepsis, acute respiratory distress syndrome and pneumomediastinum. Indian J Dermatol [serial online] 2011 [cited 2023 Mar 25];56:763-5. Available from:

   Introduction Top

Drug hypersensitivity syndrome (DHS) refers to a severe, potentially life-threatening, drug reaction. To better individualize this drug reaction, the term, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome" has recently been used. DRESS syndrome was first introduced in 1996 by Bocquet et al. [1] Skin rash and multiorgan involvement with marked eosinophilia constitute the main manifestations. The most frequently involved organ is the liver, followed by the kidney and lungs. The pathophysiology of DRESS syndrome remains unclear, but a defect in detoxification of causative drug, immunologic imbalance, and viral infections have been suggested. [2] The overall mortality in DRESS is about 10% and occurs in patients with severe multiorgan involvement. [1] Here, we present a case of a 10-year-old girl who developed DRESS syndrome after taking phenobarbital and ultimately died of multiorgan involvement with, acute respiratory distress syndrome (ARDS), pneumomediastinum and Acinetobacter sepsis.

   Case Report Top

A 10-year-old girl presented with high-grade intermittent fever with cough for 20 days and a generalized rash for 15 days following ingestion of phenobarbital for 6 weeks. There was h/o seizures with fever from the age of 18 months, but the severity and frequency of seizures started increasing, occurring even without fever for which she was put on oral phenobarbital.

On admission, we found that the girl was toxic, febrile, icteric, with tachypnea, tachycardia, conjunctival congestion, stomatitis, and cervical, axillary and inguinal lymph node enlargement. There was a diffuse erythematous, maculopapular rash without vesiculation or blistering [Figure 1]. There were bilateral diffuse crepitations over the chest and tender hepatomegaly.
Figure 1: Diffuse rash with oral involvement

Click here to view

Initial investigations showed leukocytosis, eosinophilia (absolute eosinophil count: 1586/dl), high bilirubin, elevated liver enzymes, microscopic hematuria and minimal pyuria. Imaging studies revealed hepatomegaly with features of hepatitis, mild pericardial effusion on echocardiography, and features of diffuse pneumonitis. Initial blood culture and urine culture were negative.

The patient was put on empirical antibiotics and other supportive measures. Antibiotics were changed and steroid (i.v. dexamethasone) was added on persistence of fever and dyspnea, following which there was a short period of improvement. But after a few days, the girl again complained of sudden onset exacerbation of respiratory distress and we found that she had developed subcutaneous emphysema and pneumomediastinum [Figure 2]. The patient had intermittent high spiking fever. A repeat blood culture showed growth of Acinetobacter baumanii and we switched over to sensitive antibiotics. But the general condition deteriorated and the patient developed ARDS for which she was ventilated. She improved dramatically and was extubated after 6 days. The girl again developed fever and dyspnea 2 days postextubation. There were findings of ARDS and pneumothorax on chest X-ray. She was ventilated again but succumbed after 5 days.
Figure 2: Pneumomediastinum and subcutaneous emphysema

Click here to view

   Discussion Top

A systemic allergic reaction to anticonvulsant therapy was first described in 1950 and was named "Anticonvulsant Hypersensitivity Syndrome" when associated with phenytoin therapy. [3] It has since been known as drug hypersensitivity syndrome and is now more often referred to as DRESS syndrome which is a specific, severe, idiosyncratic drug reaction characterized by skin rash with fever, facial edema, lymphadenopathy, and visceral involvement (hepatitis, pneumonitis, myocarditis, nephritis, and colitis). The diagnosis can be difficult because many of the clinical features can be nonspecific, and the syndrome often mimics infectious, neoplastic, or rheumatologic conditions.

The diagnosis of DRESS syndrome involves three criterias: [1]

  1. Drug-induced skin eruption
  2. Eosinophillia, Absolute Eosinophil count >1500/dl, or atypical lymphocytes
  3. At least one of the following systemic abnormalities: enlarged lymph nodes at least 2 cm in diameter, hepatitis, interstitial nephropathy, interstitial lung disease, or myocardial involvement.

Anticonvulsants such as phenytoin, phenobarbital sodium, or carbamazepine, are the most common causes of DRESS syndrome. [4] Other drugs like lamotrigine, valproic acid, allopurinol, sulfasalazine, nonsteroidal anti-inflammatory drugs, nevirapine and vancomycin have also been associated with this syndrome.

An association between human herpesvirus 6 infection and the development of DRESS syndrome has been suggested in susceptible patients. [5]

Life-threatening multiorgan failure has been documented in DRESS syndrome; it carries a mortality rate of about 10%, [6] especially in patients who have liver involvement. But ARDS and pneumomediastinium have been reported only in a handful of cases.

The pathogenesis is believed to be a drug-induced hypersensitivity caused by abnormalities in the production and detoxification of its active metabolites. The condition is more common in slow acetylators. [7] A genetic predisposition may also exist, as evidenced by an increased risk in patients with a family history of DRESS syndrome. The syndrome may be related to epoxide hydrolase deficiency, which leads to accumulation of toxic metabolites, known as arene oxides, which may trigger an immunologic response.

Our patient was exposed to phenobarbital. Phenobarbital-induced fulminant hepatic failure in the setting of DRESS syndrome has been described. [8] To our knowledge, this is the first instance wherein pneumomediastinum, ARDS and sepsis together have been reported to develop in phenobarbital associated DRESS syndrome.

Early withdrawal of the offending medication is needed once the diagnosis is established. The recovery from this condition has been reported to be slow, lasting several weeks to months; recurrences have also been reported. [9]

Glucocorticoids remain the most widely used agents for treatment of DRESS syndrome and can result in clinical improvement, although well-controlled clinical trials are lacking. Relapse can occur during the tapering of glucocorticoids. [10] Successful use of i.v. immuneglobulin in nevirapine-induced DRESS syndrome has been reported, [11] as well as N-acetylcysteine in a patient with sulfasalazine-induced DRESS syndrome. [12]

   References Top

1.Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) Semin Cutan Med Surg 1996;15:250-7.  Back to cited text no. 1
2.Sullivan JR, Shear NH. The drug hypersensitivity syndrome: What is the pathogenesis. Arch Dermatol 2001;137:357-64.  Back to cited text no. 2
3.Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity: Report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med 1950;242:897-8.  Back to cited text no. 3
4.lachgar T, Touil Y. The drug hypersensitivity syndrome or DRESS syndrome to Phenobarbital . Allerg Immunol (Paris) 2001;33:173-5.  Back to cited text no. 4
5.Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137:301-4.  Back to cited text no. 5
6.Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 2002;8:5.  Back to cited text no. 6
7.Rieder MJ, Shear NH, Kanee A, Tang BK, Spielberg SP. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther 1991;49:13-7.  Back to cited text no. 7
8.Syn WK, Naisbitt DJ, Holt AP, Pirmohamed M, Mutimer DJ. Carbamazepine-induced acute liver failure as part of the DRESS syndrome [published correction appears in Int J Clin Pract. 2005;59:1371]. Int J Clin Pract 2005;59:988-91.  Back to cited text no. 8
9.Valencak J, Ortiz-Urda S, Heere-Ress E, Kunstfeld R, Base W. Carbamazepine-induced DRESS syndrome with recurrent fever and exanthema. Int J Dermatol 2004;43:51-4.  Back to cited text no. 9
10.Kaminsky A, Moreno M, Diaz M, Charas V, Bravo G, Kien C. Anticonvulsant hypersensitivity syndrome. Int J Dermatol 2005;44:594-8.  Back to cited text no. 10
11.Fields KS, Petersen MJ, Chiao E, Tristani-Firouzi P. Case reports: Treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG). J Drugs Dermatol 2005;4:510-3.  Back to cited text no. 11
12.Gabay C, De Bandt M, Palazzo E. Sulphasalazine-related life-threatening side effects: Is N-acetylcysteine of therapeutic value? Clin Exp Rheumatol 1993;11:417-20.  Back to cited text no. 12


  [Figure 1], [Figure 2]

This article has been cited by
1 Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis
Natsumi Hama, Riichiro Abe, Andrew Gibson, Elizabeth J. Phillips
The Journal of Allergy and Clinical Immunology: In Practice. 2022;
[Pubmed] | [DOI]
2 Quetiapine-induced drug rash with eosinophilia and systemic symptom syndrome
RoshniAcha Biju, Sandhra Davis, Ganga Sanal
Journal of Medical Sciences. 2022; 42(5): 242
[Pubmed] | [DOI]
3 Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: A systematic review of the literature
Grace Y. Kim, Katelyn R. Anderson, Dawn M.R. Davis, Jennifer L. Hand, Megha M. Tollefson
Journal of the American Academy of Dermatology. 2020; 83(5): 1323
[Pubmed] | [DOI]
4 Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019
Tetsuo Shiohara, Yoshiko Mizukawa
Allergology International. 2019; 68(3): 301
[Pubmed] | [DOI]
5 Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
S. Ständer,D. Metze,T. Luger,T. Schwarz
Der Hautarzt. 2013; 64(8): 611
[Pubmed] | [DOI]
6 Atteintes bronchopulmonaires au cours des toxidermies graves
N. Prost,A. Mekontso-Dessap,L. Valeyrie-Allanore,B. Maître
Réanimation. 2013; 22(1): 73
[Pubmed] | [DOI]


Print this article  Email this article
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Article in PDF (813 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

   Case Report
    Article Figures

 Article Access Statistics
    PDF Downloaded100    
    Comments [Add]    
    Cited by others 6    

Recommend this journal